Benzinga | May 5, 2021 04:51PM EDT

Arena Pharmaceuticals Q1 EPS $(1.98) Beats $(2.16) Estimate

Arena Pharmaceuticals (NASDAQ:ARNA) reported quarterly losses of $(1.98) per share which beat the analyst consensus estimate of $(2.16) by 8.33 percent. This is a 1 percent increase over losses of $(2.00) per share from the same period last year.